| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 21,200 | $30 | $720.9K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 72,400 | $1 | $289.6K |
| J9312 | Injection, rituximab, 10 mg | 2,900 | $60 | $182.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,400 | $30 | $114.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 7,920 | $10 | $79.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $110 | $58.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 710 | $70 | $47.9K |
| J0897 | Injection, denosumab, 1 mg | 2,580 | $20 | $46.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 420 | $60 | $25.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 200 | $100 | $19K |